Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3,518 | 3,252 | 3,522 | 3,254 | 3,742 |
| Cost of Goods | 1,369 | 1,340 | 1,335 | 1,233 | 1,548 |
| Gross Profit | 2,149 | 1,912 | 2,187 | 2,021 | 2,194 |
| Operating Expenses | 2,312 | 2,569 | 2,722 | 2,903 | 2,945 |
| Operating Income | 206 | -317 | -200 | -649 | -203 |
| Interest Expense | 0 | 0 | 1 | 1 | 0 |
| Other Income | -23 | 28 | 32 | -4 | 21 |
| Pre-tax Income | 183 | -289 | -169 | -654 | -182 |
| Net Income Continuous | 183 | -289 | -169 | -654 | -182 |
| Net Income | $183 | $-289 | $-169 | $-654 | $-182 |
| EPS Basic Total Ops | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 |
| EPS Basic Continuous Ops | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 |
| EPS Diluted Total Ops | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 |
| EPS Diluted Continuous Ops | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.02 | -0.03 | -0.02 | N/A | N/A |
| EBITDA(a) | $239 | $-282 | $-166 | $-598 | $-147 |